Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2014
08/21/2014WO2014102596A3 Cyclic cationic peptides with antibmicrobial activity
08/21/2014WO2014088935A3 Compositions of beta-mannanase and methods of use
08/21/2014WO2014071405A3 Long-acting single-chain insulin analogues
08/21/2014US20140237689 Metabolic regulators
08/21/2014US20140237632 Rapidly maturing fluroscent proteins and methods for using the same
08/21/2014US20140237631 Neurovirulent Strain of the West Nile Virus and Uses Thereof
08/21/2014US20140236070 Linear expression cassettes and uses thereof
08/21/2014US20140235836 Immunologic Constructs and Methods
08/21/2014US20140235832 Rank ligand polypeptides
08/21/2014US20140235829 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
08/21/2014US20140235826 Optically-based stimulation of target cells and modifications thereto
08/21/2014US20140235823 Fusion protein containing a single-stranded dna binding protein and methods for expression and purification of the same
08/21/2014US20140235820 METHODS AND COMPOSITIONS FOR MODULATING THE Wnt PATHWAY
08/21/2014US20140235789 Solid phase peptide synthesis via side chain attachment
08/21/2014US20140235564 Methods for treating neural cell swelling
08/21/2014US20140235557 Small Efficient Cell Penetrating Peptides Derived From The Scorpion Toxin Maurocalcine
08/21/2014US20140235554 Ophthalmic formulation derived from silk protein
08/21/2014US20140235549 Stabilized polypeptides as regulators of rab gtpase function
08/21/2014US20140235538 Stabilized Insulin-like Growth Factor Polypeptides
08/21/2014US20140235537 N-glycosylated insulin analogues
08/21/2014US20140235535 Engineered polypeptides having enhanced duration of action with reduced immunogenicity
08/21/2014US20140235534 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
08/21/2014US20140235467 Protease-Resistant Systems for Polypeptide Display and Methods of Making and Using Thereof
08/21/2014US20140234962 Ligands Modified by Circular Permutation as Agonists and Antagonists
08/21/2014US20140234948 Molecular motor
08/21/2014US20140234945 Transthyretin variants
08/21/2014US20140234943 Viruses Lacking Epithelial Cell Receptor Entry
08/21/2014US20140234903 Biosynthetic gene cluster for the production of peptide/protein analogues
08/21/2014US20140234901 Method for Secretory Production of Protein
08/21/2014US20140234900 Methods for the release of virus-like particles
08/21/2014US20140234868 Use for glycolipoprotein gintonin, isolated and identified from ginseng, as a natural medical-plant derived ligand
08/21/2014US20140234570 Method of producing flat cocoon product and flat cocoon product
08/21/2014US20140234401 Method of treating inflammation using human immunosuppressive protein
08/21/2014US20140234363 Polypeptides from non-typeable haemophilus influenzae
08/21/2014US20140234362 Defensin-antigen fusion proteins
08/21/2014US20140234361 Novel expression vectors and uses thereof
08/21/2014US20140234359 Plant viral vaccines and therapeutics
08/21/2014US20140234357 H5 proteins of h5n1 influenza virus for use as a medicament
08/21/2014US20140234356 Influenza antigen delivery vectors and constructs
08/21/2014US20140234355 Infectious clones of torque teno virus
08/21/2014US20140234352 B7-h3 and b7-h4, novel immunoregulatory molecules
08/21/2014US20140234348 Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
08/21/2014US20140234334 Peptides and related molecules that bind to tall-1
08/21/2014US20140234326 Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of tm4sf4 in non-small cell lung cancer
08/21/2014US20140234316 Vaccibodies targeted to cross-presenting dendritic cells
08/21/2014US20140234311 Albumin variants
08/21/2014US20140234310 Compositions and methods for treatment of bacterial and mycobacterial infections
08/21/2014US20140234309 Antibody-mediated transduction of heat shock proteins into living cells
08/21/2014US20140234306 Agent and Method for Reducing Inflammatory Markers
08/21/2014US20140234292 Process for Producing a Plasma Protein-Containing Medicament
08/21/2014US20140234291 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
08/21/2014US20140234274 Directed Evolution and In Vitro Panning of Virus Vectors
08/21/2014US20140234255 Microdystrophin peptides and methods for treating muscular dystrophy using the same
08/21/2014US20140234221 Antigen-binding proteins comprising recombinant protein scaffolds
08/21/2014DE112012004586T5 Pflanzen mit erhöhter Toleranz gegenüber Herbiziden Plants with increased tolerance to herbicides
08/21/2014CA2807162A1 Solid phase peptide synthesis via side chain attachment
08/20/2014EP2767829A1 A method for identifying bitter principles and bitter-modulating principles
08/20/2014EP2767547A1 Proteinaceous protease inhibitor and protein solution and detergent composition containing it
08/20/2014EP2767546A1 Lipoprotein complexes and manufacturing and uses therof
08/20/2014EP2767545A1 Method for producing peptide
08/20/2014EP2767290A1 Amino acid sequences for controlling pathogens
08/20/2014EP2767161A1 Method for generating an non-human animal homozygous for a genetic modification
08/20/2014EP2766484A2 Regulation of receptor expression through delivery of artificial transcription factors
08/20/2014EP2766391A1 Canine/feline cd20 binding epitope and compositions for binding thereto
08/20/2014EP2766390A1 Compositions and methods for treating heart failure
08/20/2014EP2766389A2 Gene cluster for biosynthesis of griselimycin and methylgriselimycin
08/20/2014EP2766388A1 Peptides derived from campylobacter jejuni and their use in vaccination
08/20/2014EP2766387A1 Products useful for the treatment of malignant neoplasms of the human nervous system
08/20/2014EP2766386A1 Self-assembling peptide nanoparticles as vaccines against infection with norovirus
08/20/2014EP2766385A2 Cmv antigens and uses thereof
08/20/2014EP2766384A1 Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response
08/20/2014EP2766034A1 Zymogen activators
08/19/2014US8809653 Inbred corn line BC110
08/19/2014US8809652 Inbred corn line LM3
08/19/2014US8809651 Inbred corn line BB93
08/19/2014US8809650 Maize variety inbred PH1MHD
08/19/2014US8809630 Polynucleotides and polypeptides in plants
08/19/2014US8809516 Therapeutic compositions
08/19/2014US8809511 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
08/19/2014US8809510 Method for purification of complement factor H
08/19/2014US8809504 Inhibitor which is deactivatable by a reagent produced by a target cell
08/19/2014US8809503 Optimized Fc variants and methods for their generation
08/19/2014US8809501 Nucleophilic catalysts for oxime linkage
08/19/2014US8809500 Complexes comprising mammalian raptor polypeptide and mammalian mTOR polypeptide
08/19/2014US8809499 Fusion protein of human fibroblast growth factor-21 and exendin-4
08/19/2014US8809497 Compounds and methods for the treatment of vascular disease
08/19/2014US8809495 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
08/19/2014US8809279 Peptides that are modulators of the protein TRF2 and compositions containing same
08/19/2014US8809271 Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
08/19/2014US8809269 Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
08/19/2014US8809259 Charged nutritive proteins and methods
08/19/2014US8809258 Method for producing peptide
08/19/2014US8809257 Compositions and methods for promoting wound healing and tissue regeneration
08/19/2014US8809060 Ethanol-resistant yeast gene, and use thereof
08/19/2014US8809058 Helper virus-free AAV production
08/19/2014US8809051 Transgenic mammals having human Ig loci including plural VH and Vκ regions and antibodies produced therefrom
08/19/2014US8809047 Herpes simplex virus vaccines
08/19/2014US8809011 HIFα hydroxylation assay
08/19/2014US8809004 Detection of feline immunodeficiency virus
08/19/2014US8809001 High throughput assays for inhibitors and activators of PAQR receptors
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 2916